This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hillier, L.D., Lennon, G. et al. 1996. Genome Res. 6: 807–828.
Aaronson, J.S. et al. 1996. Genome Res. 6: 829–845.
Bassett, D.E. Jr. et al. 1997. Nat. Genet. 15: 339–344.
Brown, M.S. and Goldstein, J.L. 1986. Science 232: 34–47.
Brown, M.S. and Goldstein, J.L. 1996. Science 272: 629.
Fey, R. and Pearson, N. 1996. Lancet 347: 1389–1390.
Miklos, G.L. and Rubin, G.M. 1996. Cell 86: 521–529.
Hodgkin, J. et al. 1995. Science 270: 410–414.
Karim, F.D. et al. 1996. Genetics 143: 315–329.
Therrien, M. et al. 1995. Cell 83: 879–888.
Artavanis-Tsakonas, S. et al. 1995. Science 268: 225–232.
Christine, M. et al. 1997. Cell 90: 281–291.
Duojia, P. and Rubin, G.M. 1997. Cell 90: 271–280.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Scangos, G. Drug discovery in the postgenomic era. Nat Biotechnol 15, 1220–1221 (1997). https://doi.org/10.1038/nbt1197-1220
Issue Date:
DOI: https://doi.org/10.1038/nbt1197-1220
This article is cited by
-
‘Genomics’: Buzzword or reality?
Journal of Biomedical Science (1999)
-
Why pharmacogenomics? Why now?
Nature Biotechnology (1998)
-
Why pharmacogenomics? Why now?
Nature Biotechnology (1998)